Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up stud
Nucleos(t)ide analogues strongly inhibit viral replication in chronic hepatitis B (CHB) infection, b...
About 350–400 million people are infected with hepatitis B virus (HBV) chronically and 1 million peo...
Background & Aims: About 350-400 million people are infected with hepatitis B virus (HBV) chroni...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90278/1/j.1365-2893.2011.01494.x.pd
Background: Adherence to medication is an important aspect of preventing drug resistance and treatme...
BACKGROUND: Real-life prospective data on adherence to nucleos(t)ide analogues in chronic hepatitis ...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
Yueyue Li,1,* Anni Chen,2,* Hui Wang,2 Lu Han,1 Rong Wang,1 Guoqing Zhang,2 Yongfang Yuan1 1...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
OBJECTIVE: In the treatment of chronic hepatitis-B (CHB), although viral replication load is reduced...
AimsInduction of a durable viral response is difficult to achieve in patients with chronic hepatitis...
Liguo Wang,1,* Peng Chen,2,* Chao Zheng3 1Department of Infectious Diseases, First Affiliated Hospit...
Background There are currently five approved nucleos(t)ide analogues (NUCs) for the management of ch...
Background and Aim: Although most chronic hepatitis B (CHB) patients achieve effective virological s...
Nucleos(t)ide analogues strongly inhibit viral replication in chronic hepatitis B (CHB) infection, b...
About 350–400 million people are infected with hepatitis B virus (HBV) chronically and 1 million peo...
Background & Aims: About 350-400 million people are infected with hepatitis B virus (HBV) chroni...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90278/1/j.1365-2893.2011.01494.x.pd
Background: Adherence to medication is an important aspect of preventing drug resistance and treatme...
BACKGROUND: Real-life prospective data on adherence to nucleos(t)ide analogues in chronic hepatitis ...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
Yueyue Li,1,* Anni Chen,2,* Hui Wang,2 Lu Han,1 Rong Wang,1 Guoqing Zhang,2 Yongfang Yuan1 1...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of ...
OBJECTIVE: In the treatment of chronic hepatitis-B (CHB), although viral replication load is reduced...
AimsInduction of a durable viral response is difficult to achieve in patients with chronic hepatitis...
Liguo Wang,1,* Peng Chen,2,* Chao Zheng3 1Department of Infectious Diseases, First Affiliated Hospit...
Background There are currently five approved nucleos(t)ide analogues (NUCs) for the management of ch...
Background and Aim: Although most chronic hepatitis B (CHB) patients achieve effective virological s...
Nucleos(t)ide analogues strongly inhibit viral replication in chronic hepatitis B (CHB) infection, b...
About 350–400 million people are infected with hepatitis B virus (HBV) chronically and 1 million peo...
Background & Aims: About 350-400 million people are infected with hepatitis B virus (HBV) chroni...